| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/04/1999 | EP0808306B1 New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds |
| 08/04/1999 | EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1044479C Process for preparation of anti-thrombin polypeptides |
| 08/03/1999 | US5932733 Inhibitor of thrombin |
| 08/03/1999 | US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 08/03/1999 | US5932693 The present invention relates to novel antithrombotic peptides and, more particularly, to short peptides that mediate divalent cation-independent adhesion of platelets to fibronectin. |
| 08/03/1999 | US5932603 Orally administering 6-amidino-2-naphthyl4-((4,5-dihydro-1h-imidazol-3-yl-)amino)be nzoate |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932593 Antiserotonin agent |
| 08/03/1999 | US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 08/03/1999 | US5932567 Thrombin inhibitors |
| 08/03/1999 | US5932213 Modified plasmin precursors with resistance to inhibitors of plasmin |
| 08/03/1999 | US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine |
| 08/03/1999 | CA2002924C Anti-thrombins |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037751A1 Purified populations of stem cells |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037668A1 Thrombin inhibitors |
| 07/29/1999 | WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents |
| 07/29/1999 | WO1999037611A1 Heterocyclic amidines as callicrein protease inhibitors |
| 07/29/1999 | WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2317761A1 Thrombin inhibitors |
| 07/29/1999 | CA2311729A1 Purified populations of stem cells |
| 07/28/1999 | EP0931793A1 Monoclonal antibody specific for the activated coagulation factor VII (FVIIa) and its use |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0931060A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 07/28/1999 | EP0930831A1 Flavonol containing food supplements |
| 07/28/1999 | EP0766665B1 Metalloproteinase inhibitors |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | CN1044365C Alpha, omega-diarylalkane derivs., their preparation and their use in treatment and prevention of circulatory diseases and psychosis |
| 07/27/1999 | US5929074 Vsodilator, antiallergic and antiplatelet agents |
| 07/27/1999 | US5929031 Storage stable hemoglobin solutions |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036443A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036428A1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036425A1 Platelet adp receptor inhibitors |
| 07/22/1999 | WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999021830A8 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318199A1 Platelet adp receptor inhibitors |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929572A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 07/21/1999 | EP0929547A1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | CN1223660A Method and compounds for curing diseases caused by mutations |
| 07/21/1999 | CN1223141A Liquor for treating rheumatism and arthritis |
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/20/1999 | US5925739 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII |
| 07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925635 N-(amidinophenyl) cyclourea analogs as factor XA inhibitors |
| 07/20/1999 | US5925344 Pharmaceutical composition and uses therefor |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999034823A2 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 07/15/1999 | WO1999034813A1 Supplement for dialysis patients |
| 07/15/1999 | WO1999021582A3 Application of tnf antagonists as medicaments for treating septic diseases |
| 07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/14/1999 | EP0928294A1 Method and apparatus for preparing an acellular red blood cell substitute |
| 07/14/1999 | EP0928195A1 Compositions for use in embolizing blood vessels |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0777649B1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor agonists |
| 07/14/1999 | CN1222859A Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 07/14/1999 | CN1222524A Carbohydrate derivatives |
| 07/14/1999 | CN1044121C Method for isolating coagulation factors VIII complex |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922717 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 07/13/1999 | US5922690 Having at least 2 sulfate groups per disaccharide obtained by chemical sulfation of native dermatan sulfate. |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922587 Psuedonaja textilis venom, used for the detection of lupus anticoagulant(la); increased clotting activity in presence of calcium ions, phospholipids, reduced activity in the presence of la, unaffected by a deficiency in clotting factors |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922358 Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications |
| 07/13/1999 | US5922322 Cleaves at the gamma glycine404-alanine405 peptide bond; apply to medical equipment to inhibit thrombus formation; administering to treat restenosis post-surgery, to inhibit vascular reocclusion |
| 07/13/1999 | CA2176037C Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/13/1999 | CA2000153C Antidote |
| 07/13/1999 | CA1340646C Cyclic anticoagulant peptides |
| 07/08/1999 | WO1999033803A1 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
| 07/08/1999 | WO1999033800A1 Indole derivatives as inhibitors or factor xa |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2313230A1 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |